Paradigm Biocapital Advisors LP - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 140 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
Paradigm Biocapital Advisors LP ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$13,269,000
-47.5%
287,577
-4.3%
3.51%
-51.3%
Q4 2021$25,254,000300,4347.21%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,664,409$177,556,0004.47%
Avidity Partners Management LP 2,493,800$166,187,0003.68%
Matrix Capital Management Company, LP 4,349,279$289,836,0003.30%
Integral Health Asset Management, LLC 90,000$5,998,0001.72%
Affinity Asset Advisors, LLC 77,500$5,165,0001.30%
Ghost Tree Capital, LLC 65,000$4,332,0001.27%
Ikarian Capital, LLC 200,000$13,328,0000.94%
HighVista Strategies LLC 20,596$1,373,0000.91%
SILVERARC CAPITAL MANAGEMENT, LLC 23,855$1,590,0000.90%
Woodline Partners LP 507,847$33,843,0000.55%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders